Key Takeaways
  • Most GLP-1 side effects are gastrointestinal (nausea, constipation, diarrhea) and directly related to the drug's mechanism of slowing gastric emptying. They are usually mild to moderate and temporary.
  • The first 2 weeks are typically the hardest. Side effects tend to peak 2-3 days after your injection and improve by the end of week 2 at each dose level.
  • Side effects often return briefly with each dose increase, but tend to be milder than the initial adjustment period. This is normal and expected.
  • Simple strategies like eating smaller meals, staying hydrated, eating slowly, and avoiding high-fat foods can dramatically reduce discomfort.
  • Tracking your side effects day by day reveals patterns that help you and your doctor optimize your treatment. MyWhy includes built-in side effect logging to make this easy.

Starting a GLP-1 receptor agonist like Ozempic, Wegovy, or Mounjaro is a significant decision, and one of the most common questions people have before their first injection is: What are the side effects going to feel like? The honest answer is that most people experience some side effects, particularly in the first few weeks. But according to FDA prescribing information for semaglutide, the vast majority of these side effects are gastrointestinal, mild to moderate in severity, and temporary. They are a direct consequence of the drug doing what it's designed to do: activating GLP-1 receptors that slow gastric emptying, reduce appetite, and change how your body processes food.

Understanding what to expect week by week takes the anxiety out of the process. When you know that nausea on day 3 is completely normal and will likely fade by day 10, it's much easier to stick with the treatment that could change your health. This guide walks through the first month in detail, covering both semaglutide (Ozempic/Wegovy) starting at 0.25mg and tirzepatide (Mounjaro/Zepbound) starting at 2.5mg.

Your First Month: Week by Week

Every person responds differently, but clinical trial data and real-world patient experience reveal a consistent general pattern. The National Institutes of Health notes that GLP-1 receptor agonists work by mimicking gut hormones that regulate appetite and digestion, which explains why the adjustment period is primarily gastrointestinal.

TimelineWhat You May FeelWhat's Happening
Days 1-3Mild nausea, reduced appetite, slight fatigue. Some people feel nothing at all.The drug is beginning to activate GLP-1 receptors. Gastric emptying starts to slow. Your body is encountering a new hormonal signal.
Days 4-7Nausea may peak around days 3-5, then begin to ease. Appetite noticeably reduced. Possible mild constipation or loose stools.Drug levels are rising toward their first peak (semaglutide reaches steady state over several weeks). Your digestive system is adjusting to slower motility.
Week 2 (Days 8-14)Nausea typically fading. Appetite suppression becoming the new normal. Energy levels stabilizing. You may notice you're satisfied with smaller portions.Your body is adapting to the new baseline. GI tract adjusting to a slower pace of digestion. Many patients report this is when the medication starts feeling helpful rather than uncomfortable.
Week 3-4 (Days 15-28)Most initial side effects resolved for the majority of patients. Steady appetite reduction. Some early weight loss. Routine settling in.Drug levels are approaching steady state at the starting dose. Your body has largely adjusted. This is often described as the "it's working and I feel fine" phase.
Week 5 (First Dose Increase)Side effects may return temporarily, typically milder than week 1. Nausea, appetite changes, possible fatigue for 3-7 days.Higher dose means more GLP-1 receptor activation. Your body needs another adjustment period, but it's already partially adapted to the drug's mechanism.

Weeks 1-2: The Adjustment Period

The initiation dose is deliberately low. Semaglutide starts at 0.25mg and tirzepatide at 2.5mg, both well below therapeutic levels for weight loss. The purpose of this first dose is simple: let your body adjust to the drug's mechanism before increasing to a dose that produces significant appetite suppression and weight loss.

During weeks 1 and 2, the most common experience is mild nausea that comes and goes. It's typically not the kind of nausea that disrupts your day entirely; patients describe it more as a background queasiness, particularly after eating or in the morning. Some people find that it peaks 2-3 days after their injection and fades over the following days. Others experience very little at all.

Appetite reduction starts almost immediately for many people, even at the starting dose. You may notice you think about food less, feel full faster, or simply forget to eat a snack you would normally reach for. This is the GLP-1 mechanism at work, and it's a sign the medication is doing its job.

Fatigue is common but often underreported. Eating less means taking in fewer calories, and your body needs time to adjust to a different energy intake. Make sure you're eating enough protein (many providers recommend 60-100g per day on GLP-1 therapy), staying well hydrated, and getting adequate sleep.

Weeks 3-4: Finding Your Rhythm

By the second half of your first month, most patients report that initial side effects have largely resolved. Your body has had two or more weeks to adjust to the drug, and the starting dose is low enough that the GI impact is manageable for the vast majority of people.

This is when many patients start to feel the benefits more than the drawbacks. The "food noise" that dominated your mental energy may be noticeably quieter. Portion sizes naturally decrease without you having to white-knuckle your way through meals. Some early weight loss appears on the scale, though this varies widely from person to person.

If side effects persist beyond 3-4 weeks at the starting dose without improving, it's worth discussing with your healthcare provider. Persistent side effects at the lowest dose are uncommon and may warrant adjusting your treatment plan.

After Your First Dose Increase

Around week 5, your provider will typically increase your dose: from 0.25mg to 0.5mg for semaglutide, or from 2.5mg to 5mg for tirzepatide. This is the first step up in a multi-month escalation schedule designed to gradually bring you to a therapeutic dose.

It is completely normal for side effects to return temporarily with each dose increase. However, most patients find that the adjustment period is shorter and milder than the initial one. Your body has already adapted to the drug's mechanism; it just needs to adjust to the stronger signal. Most people settle in within 3-7 days at each new dose level.

Each dose increase is a new adjustment. Don't be discouraged if nausea or appetite changes return when your dose goes up. This pattern of brief side effects at each new dose level, followed by adaptation, is the standard experience. Your doctor designed the escalation schedule specifically to give your body time to adjust at each step.

The Most Common Side Effects — and How to Manage Them

The FDA's postmarket safety data confirms that the most common GLP-1 side effects are gastrointestinal. Here's what each one feels like and what actually helps:

Nausea

Nausea is the single most reported side effect across all GLP-1 medications, occurring in roughly 40-50% of patients during dose escalation. The good news is that it is almost always temporary and highly manageable with behavioral changes.

Constipation

Slower gastric emptying means slower movement through your entire digestive tract. Constipation affects roughly 20-25% of patients and can be persistent if not actively managed.

Diarrhea

It may seem contradictory that both constipation and diarrhea appear on the same side effect list, but different patients (and different dose levels) can produce different GI responses. Diarrhea is more common during the first week at a new dose and typically resolves on its own.

Fatigue

Fatigue in the first month is usually a combination of reduced caloric intake, possible mild dehydration, and your body adjusting to a new metabolic signal. It tends to resolve as your body adapts.

Injection Site Reactions

A small percentage of patients experience redness, itching, or mild swelling at the injection site. These reactions are typically minor and short-lived.

When to Call Your Doctor

Seek medical attention if you experience any of the following:

Severe or persistent vomiting. If you cannot keep food or liquids down for more than 24 hours, or if vomiting is severe enough to cause dehydration, contact your provider immediately. Your dose may need to be reduced or the escalation schedule slowed.

Severe abdominal pain. Intense, persistent pain in the upper abdomen that radiates to the back could be a sign of pancreatitis, a rare but serious side effect. The FDA warns that patients should discontinue semaglutide if pancreatitis is suspected and not restart if confirmed.

Signs of gallbladder problems. Sudden onset of severe upper-right abdominal pain, especially after eating, with or without fever. Rapid weight loss from any cause can increase gallbladder risk, and GLP-1 medications carry a specific warning.

Allergic reactions. Swelling of the face, lips, tongue, or throat; difficulty breathing or swallowing; severe rash or itching. These are rare but require immediate medical attention.

Signs of hypoglycemia (if you also take insulin or a sulfonylurea): shakiness, sweating, confusion, rapid heartbeat. GLP-1 medications alone rarely cause low blood sugar, but the risk increases with certain diabetes medications.

When in doubt, call your provider. These medications are well-studied and have a strong safety profile, but any new or concerning symptom deserves professional evaluation. Most side effects are benign, but the ones listed above require prompt attention.

How Tracking Side Effects Helps

One of the most valuable things you can do during your first month on a GLP-1 medication is keep a simple log of how you feel each day. This isn't busywork; it produces real, actionable insights that improve your treatment.

Patterns emerge by injection day. Many patients discover that their nausea peaks on a specific day post-injection (commonly day 2 or 3) and resolves by a specific day (often day 5 or 6). Once you know your pattern, you can plan meals, activities, and even your injection day around it. Some people choose to inject on Thursday or Friday so that peak side effects fall on the weekend.

You can identify triggers. Logging what you ate alongside how you felt often reveals that certain foods (high-fat meals, large portions, carbonated drinks) make nausea significantly worse. These insights let you adjust your diet to minimize discomfort while staying well-nourished.

It transforms your doctor visits. Walking into an appointment and saying "I had moderate nausea on days 2-4 after each injection, it resolved by day 5, and it was milder after the second dose than the first" gives your provider dramatically more useful information than "I felt nauseous sometimes." This data helps them make better decisions about dose escalation timing and whether to adjust your treatment.

A GLP-1 companion app like MyWhy makes this tracking effortless. MyWhy includes built-in side effect logging alongside injection tracking, weight trends, and meal check-ins, so all your treatment data lives in one place. You can see exactly how you felt at each dose level, identify your personal patterns, and share a clear picture with your healthcare provider. See how it compares to other options in our best free GLP-1 tracking apps comparison.

The Bottom Line: Side Effects Are Temporary

The first month on a GLP-1 medication is an adjustment period. Most people experience some combination of nausea, appetite changes, and digestive shifts, particularly in the first 1-2 weeks. These side effects are a direct consequence of the medication working as intended, and they improve as your body adapts.

The dose escalation schedule exists specifically to make this transition manageable. Starting low and going slow gives your body weeks to adjust at each level before the dose increases again. Most patients who experience side effects in week 1 report feeling significantly better by week 3, and many describe the overall experience as very manageable once they learned a few simple strategies.

Stay hydrated, eat smaller meals, avoid greasy food, track how you feel, and communicate with your doctor. These simple steps make the difference between a rough first month and a smooth one. And remember: the temporary discomfort of adjustment is the bridge to a treatment that clinical trials have shown produces 15% body weight loss and meaningful improvements in cardiovascular health, metabolic markers, and quality of life.

Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. GLP-1 receptor agonists (semaglutide, tirzepatide) are prescription medications that should only be used under the supervision of a licensed healthcare provider. Do not start, stop, or change your medication without consulting your doctor. Side effect severity and duration vary by individual. For full prescribing information, refer to the FDA's semaglutide safety information or FDA's tirzepatide safety information.
M
Michael Allen Vega
Founder & Developer of MyWhy. Michael built a free GLP-1 companion app after his own weight-loss journey. Read his story.